ArticleClinical and translational radiation oncology2022

Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control.

Toshimichi Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.